GIC buys 5% stake in US healthcare tech firm IMS Health

SINGAPORE, (Reuters) - Singapore sovereign wealth fund GIC has bought a 5 per cent stake in IMS Health Holdings, a US-listed technology firm servicing the healthcare sector, for an undisclosed amount, according to a regulatory filing.

GIC Private Ltd bought common stock of IMS Health earlier this month, according to a Securities and Exchange Commission filing on Thursday.

TPG Capital owns about 48 per cent of IMS Health, which has a market value of US$8.7 billion, Thomson Reuters data shows.

GIC is ranked the world's eighth-largest fund by Sovereign Wealth Fund Institute, with an estimated US$320 billion worth of assets.

The fund has the past few months taken a series of stakes in information technology companies in emerging and developed markets.